Monoclonal TCR-redirected tumor cell killing
…, NE Harwood, PE Molloy, Y Li, BJ Cameron… - Nature medicine, 2012 - nature.com
T cell immunity can potentially eradicate malignant cells and lead to clinical remission in a
minority of patients with cancer. In the majority of these individuals, however, there is a failure …
minority of patients with cancer. In the majority of these individuals, however, there is a failure …
Identification of a titin-derived HLA-A1–presented peptide as a cross-reactive target for engineered MAGE A3–directed T cells
BJ Cameron, AB Gerry, J Dukes, JV Harper… - Science translational …, 2013 - science.org
MAGE A3, which belongs to the family of cancer-testis antigens, is an attractive target for
adoptive therapy given its reactivation in various tumors and limited expression in normal …
adoptive therapy given its reactivation in various tumors and limited expression in normal …
Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells
SJ Peacock, TJ Foster, BJ Cameron… - …, 1999 - microbiologyresearch.org
Adhesion of Staphylococcus aureus to human endothelial cells is implicated in the
pathogenesis of invasive staphylococcal disease. The adhesion to endothelial cells of isogenic …
pathogenesis of invasive staphylococcal disease. The adhesion to endothelial cells of isogenic …
Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
…, DH Sutton, B Laugel, R Moysey, BJ Cameron… - Nature medicine, 2008 - nature.com
HIV's considerable capacity to vary its HLA-I-restricted peptide antigens allows it to escape
from host cytotoxic T lymphocytes (CTLs). Nevertheless, therapeutics able to target HLA-I-…
from host cytotoxic T lymphocytes (CTLs). Nevertheless, therapeutics able to target HLA-I-…
Enlivening political science courses with Kolb's learning preference model
KL Brock, BJ Cameron - PS: Political Science & Politics, 1999 - cambridge.org
… Cameron has a BA and MA in economics and a Ph.D. in higher education. … * Thanks to
Norman Cameron and James M. Lang for their helpful suggestions and to Sherry Howse for her …
Norman Cameron and James M. Lang for their helpful suggestions and to Sherry Howse for her …
Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors
…, J Karbach, E Jäger, BJ Cameron… - The Journal of …, 2006 - journals.aai.org
Presentation of intracellular tumor-associated Ags (TAAs) in the context of HLA class I molecules
offers unique cancer-specific cell surface markers for the identification and targeting of …
offers unique cancer-specific cell surface markers for the identification and targeting of …
[HTML][HTML] An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
…, AS Powlesland, A Vuidepot, NJ Hassan, BJ Cameron… - PloS one, 2018 - journals.plos.org
Robust preclinical testing is essential to predict clinical safety and efficacy and provide data
to determine safe dose for first-in-man studies. There are a growing number of examples …
to determine safe dose for first-in-man studies. There are a growing number of examples …
Electronic laboratory reporting for the infectious diseases physician and clinical microbiologist
R Wurtz, BJ Cameron - Clinical infectious diseases, 2005 - academic.oup.com
Background One important benefit of electronic health information is the improved interface
between infectious diseases practice and public health. Electronic communicable disease …
between infectious diseases practice and public health. Electronic communicable disease …
Lost in translation: NIH funding for family medicine research remains limited
BJ Cameron, AW Bazemore… - The Journal of the …, 2016 - Am Board Family Med
Departments of Family Medicine (DFMs) in the United States consistently received around
0.2% of total research funding dollars and 0.3% of all awards awarded by the National …
0.2% of total research funding dollars and 0.3% of all awards awarded by the National …
Blood group glycolipids as epithelial cell receptors for Candida albicans
BJ Cameron, LJ Douglas - Infection and immunity, 1996 - Am Soc Microbiol
The role of glycosphingolipids as possible epithelial cell receptors for Candida albicans was
examined by investigating the binding of biotinylated yeasts to lipids extracted from human …
examined by investigating the binding of biotinylated yeasts to lipids extracted from human …